TY - JOUR
T1 - Potential role of the gaseous mediator hydrogen sulphide (H2S) in inhibition of human colonic contractility
AU - Martinez-Cutillas, M.
AU - Gil, V.
AU - Mañé, N.
AU - Clavé, P.
AU - Gallego, D.
AU - Martin, M. T.
AU - Jimenez, M.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - © 2015 Published by Elsevier Ltd. Background Hydrogen sulphide (H2S) is an endogenous signalling molecule that might play a physiologically relevant role in gastrointestinal motility. Cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE) are two enzymes responsible for H2S production. d,l-Propargylglycine (PAG) is a CSE inhibitor whereas both aminooxyacetic acid (AOAA) and hydroxylamine (HA) are CBS inhibitors. The characterization of H2S responses and its mechanism of action are crucial to define H2S function. Methods Human colonic strips were used to investigate the role of H2S on contractility (muscle bath) and smooth muscle electrophysiology (microelectrodes). NaHS was used as a H2S donor. Results Combination of PAG and AOAA depolarized the smooth muscle (5-6 mV, n = 4) and elicited a transient increase in tone (260.5 ± 92.8 mg, n = 12). No effect was observed on neural mediated inhibitory junction potential or relaxation. In the presence of tetrodotoxin 1 μM, NaHS concentration-dependently inhibited spontaneous contractions (EC50 = 329.2 μM, n = 18). This effect was partially reduced by the guanylyl cyclase inhibitor ODQ 10 μM (EC50 = 2.6 μM, n = 12) and by l-NNA 1 mM (EC50 = 1.4 mM, n = 8). NaHS reversibly blocked neural mediated cholinergic (EC50 = 2 mM) and tachykinergic (EC50 = 5.7 mM) contractions. NaHS concentration-dependently reduced the increase in spontaneous mechanical activity (AUC) induced by carbachol (EC50 = 1.9 mM) and NKA (EC50 = 1.7 mM AUC). Conclusions H2S might be an endogenous gasomediator regulating human colonic contractility. Its inhibitory effect is observed at high concentrations and could be mediated by a direct effect on smooth muscle with a possible synergistic effect with NO, as well as by an interaction with the cholinergic and tachykinergic neural mediated pathways.
AB - © 2015 Published by Elsevier Ltd. Background Hydrogen sulphide (H2S) is an endogenous signalling molecule that might play a physiologically relevant role in gastrointestinal motility. Cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE) are two enzymes responsible for H2S production. d,l-Propargylglycine (PAG) is a CSE inhibitor whereas both aminooxyacetic acid (AOAA) and hydroxylamine (HA) are CBS inhibitors. The characterization of H2S responses and its mechanism of action are crucial to define H2S function. Methods Human colonic strips were used to investigate the role of H2S on contractility (muscle bath) and smooth muscle electrophysiology (microelectrodes). NaHS was used as a H2S donor. Results Combination of PAG and AOAA depolarized the smooth muscle (5-6 mV, n = 4) and elicited a transient increase in tone (260.5 ± 92.8 mg, n = 12). No effect was observed on neural mediated inhibitory junction potential or relaxation. In the presence of tetrodotoxin 1 μM, NaHS concentration-dependently inhibited spontaneous contractions (EC50 = 329.2 μM, n = 18). This effect was partially reduced by the guanylyl cyclase inhibitor ODQ 10 μM (EC50 = 2.6 μM, n = 12) and by l-NNA 1 mM (EC50 = 1.4 mM, n = 8). NaHS reversibly blocked neural mediated cholinergic (EC50 = 2 mM) and tachykinergic (EC50 = 5.7 mM) contractions. NaHS concentration-dependently reduced the increase in spontaneous mechanical activity (AUC) induced by carbachol (EC50 = 1.9 mM) and NKA (EC50 = 1.7 mM AUC). Conclusions H2S might be an endogenous gasomediator regulating human colonic contractility. Its inhibitory effect is observed at high concentrations and could be mediated by a direct effect on smooth muscle with a possible synergistic effect with NO, as well as by an interaction with the cholinergic and tachykinergic neural mediated pathways.
KW - Contractility
KW - Human colonic smooth muscle
KW - Hydrogen sulphide (H2S)
KW - Inhibitory junction potential
U2 - 10.1016/j.phrs.2015.01.002
DO - 10.1016/j.phrs.2015.01.002
M3 - Article
VL - 93
SP - 52
EP - 63
JO - Pharmacological Research
JF - Pharmacological Research
SN - 1043-6618
ER -